An Integrated Algorithm for Surgical Intervention in Chronic Lymphedema After Breast Cancer Treatment: The Basel Lymphedema Protocol

Conditions

• Breast Cancer
• Lymphedema

Eligibility Criteria

Sex

ALL

Age

N/A - N/A

Healthy Volunteers

Not accepted

Study Details

The primary objective of the investigators is to develop an integrated algorithm for surgical treatment of chronic lymphedema after breast cancer surgery. This will be achieved by retrospectively analysing a subgroup of patients who had breast cancer-related surgery prior to lymphedema.

Key Dates

First listed

Apr 19, 2024

Start date

Jan 2, 2015

Status verified

Feb 2025

Primary completion

Dec 31, 2035

Completion

Dec 31, 2035

Study Design

Enrollment

500 participants (estimated)

Primary Outcome Measure

To design an integrated algorithm for surgical treatment of chronic lymphedema after breast cancer surgery. [ Time Frame: baseline to follow up (no later than December 2024) ]

Central Contacts

• Elisabeth A Kappos, PD Dr. med
  0041 61 265 25 25
  [email protected]
• Adriano Fabi, BMed
  0041 79 888 12 51
  [email protected]

Find similar trials

Related Studies

• Collection of Blood From Patients With Cancer
  Recruiting · National Cancer Institute (NCI) · Bethesda, Maryland
• Harvesting Cells for Experimental Cancer Treatments
  Enrolling By Invitation · National Cancer Institute (NCI) · Bethesda, Maryland
• High Risk Breast Clinic: Protocol for Women at Increased Risk for Developing Breast Cancer
  Recruiting · Carol Fabian, MD · Kansas City, Kansas
• Follow-Up Study of Subjects Previously Enrolled in Poxviral Vector Gene Transfer Studies
  Recruiting · National Cancer Institute (NCI) · Bethesda, Maryland